Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease - PubMed (original) (raw)

Review

Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease

Rebecca C Schugar et al. Curr Opin Clin Nutr Metab Care. 2012 Jul.

Abstract

Purpose of review: Obesity-associated nonalcoholic fatty liver disease (NAFLD) is highly prevalent, for which weight loss is the generally recommended clinical management. Low-carbohydrate ketogenic diets have been successful in promoting weight loss, but variations in the range of metabolic responses to these diets indicate that the effects of altering macronutrient content are not completely understood. This review focuses on the most recent findings that reveal the relationship between low-carbohydrate diets and NAFLD in rodent models and humans.

Recent findings: Low-carbohydrate diets have been shown to promote weight loss, decrease intrahepatic triglyceride content, and improve metabolic parameters of patients with obesity. These ketogenic diets also provoke weight loss in rodents. However, long-term maintenance on a ketogenic diet stimulates the development of NAFLD and systemic glucose intolerance in mice. The relationship between ketogenic diets and systemic insulin resistance in both humans and rodents remains to be elucidated.

Summary: Because low-carbohydrate ketogenic diets are increasingly employed for treatment of obesity, NAFLD, and neurological diseases such as epilepsy, understanding the long-term systemic effects of low-carbohydrate diets is crucial to the development of efficacious and safe dietary interventions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115(12):1544–50. - PubMed
    1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41. - PubMed
    2. Overall, obesity affects 35.5% and 35.8% of U.S. men and women, respectively. This study of 5555 patients examines the prevalence of obesity in the population according to age and ethnicity.
    1. Brookheart RT, Michel CI, Schaffer JE. As a matter of fat. Cell Metab. 2009;10(1):9–12. - PMC - PubMed
    1. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430–5. - PMC - PubMed
    1. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7(4):195–203. - PubMed
    2. Study focuses on the state-of-the-art histological hallmarks of NAFLD disease progression.

Publication types

MeSH terms

Substances

LinkOut - more resources